Avalo Therapeutics, Inc.(AVTX)Earnings Date, History & Expected Move
Next report date, beat rate and options-implied move
AVTX is scheduled to report on Nov 4, 2026, usually before the market opens. Analysts expect EPS of -$0.63.
EPS: Actual vs Estimate
Reported EPS against the consensus estimate, last 12 quarters.
Green beat or met, red missed, amber sources differ.
Stock Reaction After Earnings
Close-to-close move in the first session that reflected each report.
Dashed lines mark the average actual move (±3.6%).
Did the stock rise after good news?
The next-day move after each of its last 5 EPS beats and 4 misses.
In plain words: it beat expectations 5 times, but the stock still fell 4 of those 5 times.
- Aug '26Missed▼ -0.7%
- May '26Beat▼ -0.5%
- Mar '26Beat▲ +0.6%
- Nov '25Missed▼ -6.3%
- Mar '25Missed▲ +2.9%
- Nov '24Beat▼ -3.7%
- Aug '24Beat▼ -7.3%
- May '24Missed▼ -0.3%
- Nov '23Beat▼ -10.1%
Clear beats and misses with a known reaction only. What counts as a beat
Why did AVTX fall after beating earnings?
5 of AVTX's last 9 reactions went against the EPS result. What stands out in each:
AVTX beat EPS estimates in 5 quarters, and the stock still closed lower the next day 4 times. In 3 of the 4 where we have price data, the stock had already run up before the report.
- May 13, 2026EPS beat +4.9%stock -0.5% next day
- It had risen 43.5% in the 20 trading sessions before the report, so good news may already have been priced in.
- It opened 1.4% higher, but sellers took over and it closed -0.5%.
- Nov 7, 2024EPS beat +182.4%stock -3.7% next day
- It had risen 48.4% in the 20 trading sessions before the report, so good news may already have been priced in.
- It opened 7.3% lower as soon as trading resumed.
- Aug 12, 2024EPS beat +162.8%stock -7.3% next day
- It opened 1.5% lower as soon as trading resumed.
- Nov 9, 2023EPS beat +90.0%stock -10.1% next day
- It had risen 7.9% in the final week before the report, so good news may already have been priced in.
- It opened 1.8% lower as soon as trading resumed.
Rose despite an EPS miss (1 of 4)
- Mar 20, 2025EPS missed -264.1%stock +2.9% next day
Nothing in the price and estimate numbers we track stands out for this one. Guidance and management comments are not part of our data.
Patterns in estimates and prices, not confirmed causes: how we read them.
Was AVTX's earnings move already priced in?
AVTX's move in the month before each of its last 9 reports, against what it did after.
How the run-up is measured (a move of 5% or more counts as large).
Before vs after each report
Grey: the month before each of the last 9 reports. Green or red: the day after.
Past reports only. How the run-up is measured
Does AVTX hold its opening gap after earnings?
AVTX's opening move after each report and where it closed that day.
In 8 reports AVTX opened at least 1% away from the previous close. It gave back half or more of that gap by the close 5 of 8 times (63%), and fully reversed 2 times.
- Aug 6, 2026FadedOpened -5.1%, closed -0.7%
- May 13, 2026ReversedOpened +1.4%, closed -0.5%
- Nov 6, 2025HeldOpened -3.8%, closed -6.3%
- Mar 20, 2025ReversedOpened -4.3%, closed +2.9%
- Nov 7, 2024FadedOpened -7.3%, closed -3.7%
- Aug 12, 2024HeldOpened -1.5%, closed -7.3%
- May 13, 2024FadedOpened -1.8%, closed -0.3%
- Nov 9, 2023HeldOpened -1.8%, closed -10.1%
What the history says
- It fell after 4 of its 5 EPS beats (80%): beating estimates has not been enough on its own.
AVTX earnings history
Last 12 reported quarters with the stock's reaction.
Swipe sideways to see every column →
| Report date | Time | EPS est. | EPS actual | Surprise | 1-day move | 3-day move |
|---|---|---|---|---|---|---|
| Aug 6, 2026 | Before open | -$0.62 | -$0.83 | -33.9% | -0.74% | +4.94% |
| May 13, 2026 | Before open | -$1.03 | -$0.98 | +4.9% | -0.45% | -11.03% |
| Mar 23, 2026 | Before open | -$1.49 | -$0.37 | +75.2% | +0.60% | +3.95% |
| Nov 6, 2025 | Before open | -$1.64 | -$2.19 | -33.5% | -6.26% | -7.51% |
| Aug 7, 2025 | Before open | -$1.40 | -$1.92 | -37.1% | — | — |
| May 12, 2025 | Before open | -$1.60 | -$1.25 | +21.9% | — | — |
| Mar 20, 2025 | Before open | $1.67 | -$2.74 | -264.1% | +2.88% | -4.51% |
| Nov 7, 2024 | Before open | -$1.19 | $0.98 | +182.4% | -3.66% | -1.12% |
| Aug 12, 2024 | Before open | -$6.70 | $4.21 | +162.8% | -7.30% | -4.77% |
| May 13, 2024 | Before open | -$1.18 | -$141.00 | -11849.2% | -0.28% | -4.24% |
| Mar 29, 2024 | After close | -$4.80 | -$113.04 | -2255.0% | — | — |
| Nov 9, 2023 | Before open | -$264.00 | -$26.40 | +90.0% | -10.09% | -16.51% |
Consensus for the next report: EPS -$0.63, revenue $0.00.
AVTX Earnings FAQ
Answers computed from Avalo Therapeutics, Inc.'s reported history
AVTX is scheduled to report on Nov 4, 2026, usually before the market opens. Analysts expect EPS of -$0.63.
Over the last 12 quarters with a usable EPS surprise, AVTX beat the consensus estimate 6 times (50%), missed 6 and landed in line 0.
Across its last 9 quarters with a measured reaction, AVTX moved an average of ±3.6% in the first session after reporting. It closed higher 22% of the time; the largest gain was 2.9% and the largest drop -10.1%.
AVTX fell in the first session after 4 of its last 5 EPS beats (80%). A beat that was already priced in, or weaker guidance, can send a stock lower. In 3 of the 4 of those falls where price data is available, the stock had already risen before the report.
Across its last 9 quarters with price data, AVTX moved an average of +4.7% in the 20 trading sessions before reporting and was higher in 44% of them. After a run-up of 3% or more (4 quarters), it fell the next day 75% of the time, averaging -1.9%. After a drop of 3% or more (4 quarters), it rose the next day 25% of the time, averaging -4.3%. This describes past reports; it is not a forecast.
In 8 reports AVTX opened at least 1% away from the previous close. It gave back half or more of that gap by the close 5 of 8 times (63%), and fully reversed 2 times. A fade means the opening move was partly undone during the first session.
How we calculate these numbers · AVTX: 12 reported quarters, latest Aug 6, 2026. Information only, not investment advice.
Looking for more on AVTX?
Price charts, forecast, fundamentals and risk pages for AVTX are not on Tickzen yet. You can run a full stock analysis now.
Run the AVTX Stock AnalyzerLatest TickZen Insights
HSBC Q3 2026 Earnings Preview: Is the $46bn NII Guide Too Low?By Vishal Jadaun
Coca-Cola (KO) Q3 2026 Earnings Preview: Can Growth Justify Its Valuation?By Vishal Jadaun
Welltower Q3 2026 Earnings Preview: Can 20% Senior Housing Growth Last?By Vishal Jadaun